(Q54744632)

3 June 2018

title

Letter: Prostaglandins and the unfavourable cervix. (English)

1 reference

3 June 2018

author name string

A Calder

series ordinal

1

1 reference

3 June 2018

M P Embrey

series ordinal

2

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 December 1973

1 reference

3 June 2018

published in

The Lancet

1 reference

3 June 2018

volume

2

1 reference

3 June 2018

issue

7841

1 reference

3 June 2018

page(s)

1322-1323

1 reference

3 June 2018

Prostaglandins for induction of therapeutic abortion

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

Induction of Abortion by Extra-amniotic Administration of Prostaglandins E2 and F2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

Termination of pregnancy by continuous intrauterine infusion of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

Use of Prostaglandin E2 in the Management of Missed Abortion, Missed Labour, and Hydatidiform Mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

The use of prostaglandin E 2 in the management of intrauterine death, missed abortion and hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

The unfavourable cervix and induction of labour using a cervical balloon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992894-8

7 January 2021

10.1016/S0140-6736(73)92894-8

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

4127662

1 reference

3 June 2018